These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1423041)
1. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Zochodne DW; Ho LT Can J Neurol Sci; 1992 Nov; 19(4):433-41. PubMed ID: 1423041 [TBL] [Abstract][Full Text] [Related]
2. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes. Cameron NE; Cotter MA Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573 [TBL] [Abstract][Full Text] [Related]
3. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats. Cotter MA; Cameron NE; Hohman TC J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252 [TBL] [Abstract][Full Text] [Related]
4. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Nangle MR; Gibson TM; Cotter MA; Cameron NE Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532 [TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats. Cotter MA; Gibson TM; Nangle MR; Cameron NE Diabetes Obes Metab; 2010 Aug; 12(8):689-99. PubMed ID: 20590746 [TBL] [Abstract][Full Text] [Related]
6. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181 [TBL] [Abstract][Full Text] [Related]
7. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Saini AK; Kumar H S A; Sharma SS Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626 [TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Kusano KF; Allendoerfer KL; Munger W; Pola R; Bosch-Marce M; Kirchmair R; Yoon YS; Curry C; Silver M; Kearney M; Asahara T; Losordo DW Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2102-7. PubMed ID: 15358602 [TBL] [Abstract][Full Text] [Related]
10. The influence of sulindac on experimental streptozotocin-induced diabetic neuropathy. Zochodne DW; Ho LT Can J Neurol Sci; 1994 Aug; 21(3):194-202. PubMed ID: 8000974 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Cameron NE; Cotter MA; Dines KC; Maxfield EK Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173 [TBL] [Abstract][Full Text] [Related]
12. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Tuck RR; Schmelzer JD; Low PA Brain; 1984 Sep; 107 ( Pt 3)():935-50. PubMed ID: 6478183 [TBL] [Abstract][Full Text] [Related]
13. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Inkster ME; Cotter MA; Cameron NE Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486 [TBL] [Abstract][Full Text] [Related]
14. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225 [TBL] [Abstract][Full Text] [Related]
16. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Sayyed SG; Kumar A; Sharma SS Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090 [TBL] [Abstract][Full Text] [Related]
17. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism. Cameron NE; Cotter MA Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947 [TBL] [Abstract][Full Text] [Related]
18. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948 [TBL] [Abstract][Full Text] [Related]
19. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Sharma SS; Sayyed SG Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909 [TBL] [Abstract][Full Text] [Related]
20. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]